{
  "id": "bb34f32e6f779c37",
  "title": "Roche receives FDA approval for first diagnostic tests to identify HER2 - positive metastatic breast cancer patients eligible for ENHERTU",
  "description": "20251215T203000Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "http://www.prnewswire.com/news-releases/roche-receives-fda-approval-for-first-diagnostic-tests-to-identify-her2-positive-metastatic-breast-cancer-patients-eligible-for-enhertu-302642587.html",
  "published_at": "20251215T203000Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "http://www.prnewswire.com/news-releases/roche-receives-fda-approval-for-first-diagnostic-tests-to-identify-her2-positive-metastatic-breast-cancer-patients-eligible-for-enhertu-302642587.html",
    "url_mobile": "",
    "title": "Roche receives FDA approval for first diagnostic tests to identify HER2 - positive metastatic breast cancer patients eligible for ENHERTU",
    "seendate": "20251215T203000Z",
    "socialimage": "https://mma.prnewswire.com/media/2845923/Roche_Pantone_coated_v2.jpg?p=facebook",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}